UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psoriasiform dermatitis in a person of colour with chronic hepatitis B

JEADV clinical practice, 2024-07, Vol.3 (3), p.882-886

2024

Volltextzugriff (PDF)

Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen

Ästhetische Dermatologie & Kosmetologie, 2023-09, Vol.15 (4), p.34-41

2023

Volltextzugriff (PDF)

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2344589-2344589

2024

Volltextzugriff (PDF)

Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups

BMC medical genetics, 2020-05, Vol.21 (1), p.102-102, Article 102

2020

Volltextzugriff (PDF)

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists

International journal of women's dermatology, 2023-12, Vol.9 (4), p.e112-e112

2023

Volltextzugriff (PDF)

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Dermatologie (Heidelberg, Germany), 2024-05, Vol.75 (5), p.417-427

2024

Volltextzugriff (PDF)

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Dermatologie (Heidelberg, Germany), 2024-05, Vol.75 (5), p.417

2024

Volltextzugriff (PDF)

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

JAAD international, 2021-03, Vol.2, p.96-97

2021

Volltextzugriff (PDF)

33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB109-AB109

2022

Volltextzugriff (PDF)

Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657

2017

Volltextzugriff (PDF)

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2020-07, Vol.396 (10246), p.255-266

2020

Volltextzugriff (PDF)

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

The lancet oncology, 2018-09, Vol.19 (9), p.1192-1204

2018

Volltextzugriff (PDF)

Trial of Intravenous Immune Globulin in Dermatomyositis

The New England journal of medicine, 2022-10, Vol.387 (14), p.1264-1278

2022

Volltextzugriff (PDF)

53979 Comparison of different skincare regimens for patients with moderate-to-severe atopic dermatitis in addition to systemic treatment: results of a multicenter randomized controlled trial

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB165-AB165

2024

Volltextzugriff (PDF)

52620 Long-term safety and efficacy of secukinumab over 236 weeks in children and adolescents with severe chronic plaque psoriasis: Results of a double-blind, randomized controlled phase III trial

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB60-AB60

2024

Volltextzugriff (PDF)

52675 Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB142-AB142

2024

Volltextzugriff (PDF)

357 The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies

British journal of dermatology (1951), 2023-01, Vol.188 (Supplement_2)

2023

Volltextzugriff (PDF)

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

The New England journal of medicine, 2022-10, Vol.387 (16), p.1445-1455

2022

Volltextzugriff (PDF)

43802 Bimekizumab in patients with moderate to severe plaque psoriasis: Injection site reactions through two years of the BE RADIANT phase 3b trial and open-label extension with one-year comparison to secukinumab

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB128-AB128

2023

Volltextzugriff (PDF)

425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

The Lancet (British edition), 2023-09, Vol.402 (10404), p.798-808

2023

Volltextzugriff (PDF)

Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial

Journal of the European Academy of Dermatology and Venereology, 2023-06, Vol.37 (S5), p.18-26

2023

Volltextzugriff (PDF)

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB119-AB119

2021

Volltextzugriff (PDF)

Pustulobullous variant of SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657-659

2017

Volltextzugriff (PDF)

Pustulobullöse Variante eines SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657-659

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)
Berichte
(1)

Sprache

Englisch
(32)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Psoriasiform dermatitis in a person of colour with chronic hepatitis B

Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study

Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema)

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Trial of Intravenous Immune Globulin in Dermatomyositis

53979 Comparison of different skincare regimens for patients with moderate-to-severe atopic dermatitis in addition to systemic treatment: results of a multicenter randomized controlled trial

52620 Long-term safety and efficacy of secukinumab over 236 weeks in children and adolescents with severe chronic plaque psoriasis: Results of a double-blind, randomized controlled phase III trial

52675 Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials

357 The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

43802 Bimekizumab in patients with moderate to severe plaque psoriasis: Injection site reactions through two years of the BE RADIANT phase 3b trial and open-label extension with one-year comparison to secukinumab

425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Pustulobullous variant of SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Pustulobullöse Variante eines SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Aktive Filter

Suchergebnisse filtern